These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5547279)

  • 1. Human norepinephrine metabolism. Its evaluation bydministration of tritiated norepinephrine.
    Gitlow SE; Mendlowitz M; Bertani LM; Wilk S; Wilkek
    J Clin Invest; 1971 Apr; 50(4):859-65. PubMed ID: 5547279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of D, L-3H-norepinephrine in essential hypertension.
    Gitlow S; Dziedzic S; Dziedzic L; Roubein I
    Clin Exp Hypertens (1978); 1981; 3(5):897-918. PubMed ID: 7026196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interconversion of O-methylated norepinephrine metabolites in humans.
    Brown RT; Polinsky RJ; Kopin IJ
    J Lab Clin Med; 1987 Jul; 110(1):119-24. PubMed ID: 3598334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension.
    Kopin IJ; Polinsky RJ; Oliver JA; Oddershede IR; Ebert MH
    J Clin Endocrinol Metab; 1983 Sep; 57(3):632-7. PubMed ID: 6874892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The investigation of adrenergic metabolism with 7H3-norepinephrine in psychiatric disorders. I. Temporal changes in the distribution of urinary tritiated metabolites and the effects of drugs.
    Rosenblatt S; Chanley JD; Leighton WP
    J Psychiatr Res; 1969 May; 6(4):307-19. PubMed ID: 5789953
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of norepinephrine secretion and production.
    Hoeldtke RD; Cilmi KM; Reichard GA; Boden G; Owen OE
    J Lab Clin Med; 1983 May; 101(5):772-82. PubMed ID: 6339653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamine turnover in normotensive and hypertensive man: effects of antiadrenergic drugs.
    DeQuattro V; Sjoerdsma A
    J Clin Invest; 1968 Oct; 47(10):2359-73. PubMed ID: 5676529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving views of the metabolic fate of norepinephrine.
    Kopin IJ
    Endocrinol Exp; 1982 Nov; 16(3-4):291-300. PubMed ID: 6983434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline.
    Schildkraut JJ; Draskoczy PR; Gershon ES; Reich P; Grab EL
    J Psychiatr Res; 1972 Sep; 9(3):173-85. PubMed ID: 5083173
    [No Abstract]   [Full Text] [Related]  

  • 10. The metabolism of circulating norepinephrine by human subjects.
    Maas JW; Landis DH
    J Pharmacol Exp Ther; 1971 Jun; 177(3):600-12. PubMed ID: 5568814
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative activity of metabolic pathways for norepinephrine in endogenous depression.
    Roy A; Linnoila M; Karoum F; Pickar D
    Acta Psychiatr Scand; 1986 Jun; 73(6):624-8. PubMed ID: 3751666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo studies of the metabolism of norepinephrine in the central nervous system.
    Maas JW; Landis DH
    J Pharmacol Exp Ther; 1968 Sep; 163(1):147-62. PubMed ID: 5673702
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma and urine catecholamine levels in cosmonauts during long-term stay on Space Station Salyut-7.
    Kvetnansky R; Davydova NA; Noskov VB; Vigas M; Popova IA; Usakov AC; Macho L; Grigoriev AI
    Acta Astronaut; 1988 Feb; 17(2):181-6. PubMed ID: 11542424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamine metabolism, depression and stress.
    Maas JW; Dekirmenjian H; Fawcett J
    Nature; 1971 Apr; 230(5292):330-1. PubMed ID: 5549410
    [No Abstract]   [Full Text] [Related]  

  • 15. Acetaldehyde mediation in the mechanism of ethanol-induced changes in norepinephrine metabolism.
    Walsh MJ; Truitt EB; Davis VE
    Mol Pharmacol; 1970 Jul; 6(4):416-24. PubMed ID: 5429284
    [No Abstract]   [Full Text] [Related]  

  • 16. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate.
    Greenspan K; Schildkraut JJ; Gordon EK; Baer L; Aronoff MS; Durell J
    J Psychiatr Res; 1970 Feb; 7(3):171-83. PubMed ID: 5440858
    [No Abstract]   [Full Text] [Related]  

  • 18. Affective disorders and norepinephrine pharmacology.
    Schildkraut JJ; Schanberg SM; Kopin IJ; Durell J
    Int Psychiatry Clin; 1969; 6(2):83-141. PubMed ID: 4897536
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis.
    Engelman K; Jéquier E; Udenfriend S; Sjoerdsma A
    J Clin Invest; 1968 Mar; 47(3):568-76. PubMed ID: 5637144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.
    Eisenhofer G; Hovevey-Sion D; Kopin IJ; Miletich R; Kirk KL; Finn R; Goldstein DS
    J Pharmacol Exp Ther; 1989 Jan; 248(1):419-27. PubMed ID: 2563292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.